Page 234 - ELT_15th May 2020_VOL 372_Part 4th
P. 234

624                         EXCISE LAW TIMES                    [ Vol. 372

                                            7.  “to restore to a good or sound 7. condition after decay or damage;
                                            mend”
                                                  (THE RANDOM HOUSE COLLEGE DICTIONARY, USA)
                                            8.  “to restore to a sound or 8. healthy state”
                                            7.  Reconditioning also is more or less synonymous with the word ‘re-
                                     pair’. To ascertain what amounts to manufacture under the Central Excise Act,
                                     1944, we refer to the definitions in Section 2 of the Act. Clause (f), sub-clause (iii)
                                     of this section specifically says that packing or reconditioning of any goods or
                                     even re-labelling of containers amounts to manufacture in respect of goods cov-
                                     ered in Third Schedule to Central Excise Tariff Act. Pharmaceutical products are
                                     covered at Sl. No. 31 of the Third Schedule to the Central Excise Tariff Act. Since
                                     the product in question is a pharmaceutical product, we also  looked into the
                                     chapter notes to Chapter 30 of Central Excise Tariff under which these products
                                     fall. Chapter Note 6 clarifies that while dealing the pharmaceutical products, re-
                                     labelling or re-labelling of the containers intended for consumers or repacking
                                     sought from bulk packs to retail boxes or for adopting of any other treatment to
                                     render the product marketable to the consumer, shall amount to ‘manufacture’.
                                     Section 2(f) of the Central Excise Act, 1944 as well as Chapter Note 6 to Chapter
                                     30 of Central Excise Tariff make it abundantly clear that repacking of pharmaceu-
                                     ticals amounts to manufacture. Any activity which gets squarely covered under
                                     the definition of ‘manufacture’ cannot be called as “repair or reconditioning” of
                                     the products. Sl. No. 14 of Annexure-I to the impugned notification exempts the
                                     products/goods imported within 3 years from the date of exportation only under
                                     the condition that the goods are re-imported either for repair or for recondition-
                                     ing. Hence  when the goods are  re-imported for an activity which amounts to
                                     manufacture, such re-importation will not fall under the impugned notification.
                                     Therefore, the exemption benefit of the  notification cannot be extended to the
                                     appellant.
                                            8.  The case laws as relied upon by the appellant have also been looked
                                     into and we are of the opinion that the same are not applicable to the facts and
                                     circumstances of the present case. We further observe that the said case laws ra-
                                     ther support the Revenue’s stand by holding that repair means that “no new or
                                     different goods emerge”.
                                            9.  The appellant also relied on C.B.E. & C.’s Circular No. 127/95, dated
                                     14-12-1995. We do not find anything in this circular which extends the benefit of
                                     the exemption Notification No. 52/2003 for re-importation of goods when those
                                     are re-imported within 3 years of exportation for an activity which amounts to
                                     manufacture. Further, we observe that the exemption notification being an ex-
                                     emption to the general rule, must be construed strictly and benefit of doubt if
                                     any must be given in favour of the Revenue and against the claimant, as held by
                                     Hon’ble Apex Court in the case of Dilipkumar (in Civil Appeal No. 3327/2007)
                                     [2018 (361) E.L.T. 577 (S.C.)].
                                            10.  In view of the above, we find that the appellant is not entitled to the
                                     benefit of exemption Notification No. 52/2003-Cus., dated 31-3-2003. Therefore,
                                     there is no infirmity in the impugned order.
                                            11.  The appeal is rejected and the impugned order is upheld.
                                                       (Dictated and pronounced in open Court)
                                                                     _______
                                                         EXCISE LAW TIMES      15th May 2020      234
   229   230   231   232   233   234   235   236